UBS Group AG - MEDTECH ACQUISITION CORP ownership

MEDTECH ACQUISITION CORP's ticker is MTACW and the CUSIP is 58507N113. A total of 33 filers reported holding MEDTECH ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MEDTECH ACQUISITION CORP
ValueSharesWeighting
Q4 2022$449
-98.9%
0.00%
Q3 2022$04,529
-0.2%
0.00%
Q2 2022$0
-100.0%
4,5390.0%0.00%
Q1 2022$1,000
-66.7%
4,539
-10.4%
0.00%
Q4 2021$3,000
-40.0%
5,064
-15.7%
0.00%
Q3 2021$5,0006,006
+3958.1%
0.00%
Q1 2021$01480.00%
Other shareholders
MEDTECH ACQUISITION CORP shareholders Q2 2022
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 500,000$4,900,0000.26%
ANGELO GORDON & CO., L.P. 95,808$939,0000.11%
CastleKnight Management LP 46,371$454,0000.06%
Radcliffe Capital Management, L.P. 138,194$1,354,0000.03%
Q Global Advisors, LLC 49,561$13,0000.01%
MYDA Advisors LLC 42,949$11,0000.00%
Magnetar Financial LLC 1,243,264$315,0000.00%
Kepos Capital LP 145,000$37,0000.00%
Bracebridge Capital, LLC 98,857$25,0000.00%
SPRING CREEK CAPITAL LLC 167,566$42,0000.00%
View complete list of MEDTECH ACQUISITION CORP shareholders